论文部分内容阅读
目的评估个案追踪化监护在慢性心力衰竭(下称心衰)治疗中的效果。方法以入选的130例慢性心衰患者为研究对象,以双盲分组进行一项单中心对照研究,其中追踪监护组(n=65)在治疗周期实施全病程个案追踪化监护,对照组(n=65)仍沿用传统护理方法,两组均加强院内病情观察及院外随访,整个试验观察期为半年,观察期结束时对两组治疗前后左室舒张末期内径(LVED)、左室射血分数(LVEF)、6min步行试验(6MWT)及血浆脑钠肽水平进行评价,采用MLH-FQ心衰测量工具评价两组随访周期生活质量的差异性。结果末次评价显示,两组BNP水平的差异性不显著(P>0.05),而心功能指标LVED、LVEF、6MWT等的改善情况,追踪监护组均优于对照组(P<0.05);同时,追踪监护组MLH-FQ评分较对照组有所降低(P<0.05),提示追踪监护组治疗6个月时的生活质量状况优于对照组。结论个案追踪化监护有利于慢性心衰患者改善心功能并促进生活质量的提高,为严重性心脏疾病的康复治疗提供了护理保证。
Objective To evaluate the effect of follow-up monitoring in the treatment of chronic heart failure (hereinafter referred to as heart failure). Methods One hundred and thirty patients with chronic heart failure were enrolled in this study. A single-center controlled study was conducted in double-blind groups. The follow-up monitoring group (n = 65) = 65) still follow the traditional method of nursing, both of which strengthen the hospital condition observation and hospital follow-up, the entire trial period of six months, the end of the observation period before and after treatment of left ventricular end-diastolic diameter (LVED), left ventricular ejection fraction (LVEF), 6-minute walk test (6MWT) and plasma brain natriuretic peptide were used to evaluate the difference of quality of life between follow-up cycles by MLH-FQ heart failure measuring tool. Results The final evaluation showed that there was no significant difference in BNP level between the two groups (P> 0.05). However, the improvement of LVED, LVEF and 6MWT were better than the control group (P <0.05) The MLH-FQ score of follow-up care group was lower than that of control group (P <0.05), which indicated that the quality of life condition of follow-up care group was better than that of control group at 6 months. Conclusion Case-based monitoring is beneficial to patients with chronic heart failure to improve cardiac function and improve the quality of life, providing a guarantee for the rehabilitation of severe heart disease.